As of 2025-12-28, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -14.84 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 20.04 USD, the upside of Dyne Therapeutics Inc is -174.04%.
Based on its market price of 20.04 USD and our intrinsic valuation, Dyne Therapeutics Inc (DYN) is overvalued by 174.04%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -14.84 - -14.84 | -14.84 | -174.04% |
| P/E | (27.24) - (46.83) | (37.17) | -285.5% |
| DDM - Stable | (19.98) - (59.16) | (39.57) | -297.5% |
| DDM - Multi | (0.33) - (0.73) | (0.45) | -102.2% |
| Market Cap (mil) | 2,862.11 |
| Beta | 1.72 |
| Outstanding shares (mil) | 142.82 |
| Enterprise Value (mil) | 2,387.65 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.45% |
| Cost of Debt | 5.00% |
| WACC | 7.56% |